257 related articles for article (PubMed ID: 9457811)
1. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.
Sneed PK; Stauffer PR; McDermott MW; Diederich CJ; Lamborn KR; Prados MD; Chang S; Weaver KA; Spry L; Malec MK; Lamb SA; Voss B; Davis RL; Wara WM; Larson DA; Phillips TL; Gutin PH
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):287-95. PubMed ID: 9457811
[TBL] [Abstract][Full Text] [Related]
2. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
3. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
[TBL] [Abstract][Full Text] [Related]
4. Interstitial irradiation versus interstitial thermoradiotherapy for supratentorial malignant gliomas: a comparative survival analysis.
Stea B; Rossman K; Kittelson J; Shetter A; Hamilton A; Cassady JR
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):591-600. PubMed ID: 7928490
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
[TBL] [Abstract][Full Text] [Related]
6. GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study.
Welsh J; Sanan A; Gabayan AJ; Green SB; Lustig R; Burri S; Kwong E; Stea B
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):159-65. PubMed ID: 17331666
[TBL] [Abstract][Full Text] [Related]
7. Interstitial thermoradiotherapy of brain tumors: preliminary results of a phase I clinical trial.
Stea B; Cetas TC; Cassady JR; Guthkelch AN; Iacono R; Lulu B; Lutz W; Obbens E; Rossman K; Seeger J
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1463-71. PubMed ID: 2175738
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme.
Sneed PK; Lamborn KR; Larson DA; Prados MD; Malec MK; McDermott MW; Weaver KA; Phillips TL; Wara WM; Gutin PH
Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):37-44. PubMed ID: 8641924
[TBL] [Abstract][Full Text] [Related]
9. Interstitial brachytherapy procedures for brain tumors.
Sneed PK; McDermott MW; Gutin PH
Semin Surg Oncol; 1997; 13(3):157-66. PubMed ID: 9143053
[TBL] [Abstract][Full Text] [Related]
10. Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost.
Sneed PK; Prados MD; McDermott MW; Larson DA; Malec MK; Lamborn KR; Davis RL; Weaver KA; Wara WM; Phillips TL
Neurosurgery; 1995 May; 36(5):898-903; discussion 903-4. PubMed ID: 7791979
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
[TBL] [Abstract][Full Text] [Related]
12. High-dose-rate stereotactic brachytherapy for patients with newly diagnosed glioblastoma multiformes.
Chang CN; Chen WC; Wei KC; Ng SH; Ho YS; Huang DY; Lee SP; Hong JH
J Neurooncol; 2003 Jan; 61(1):45-55. PubMed ID: 12587795
[TBL] [Abstract][Full Text] [Related]
13. Treatment of malignant gliomas with interstitial irradiation and hyperthermia.
Stea B; Kittelson J; Cassady JR; Hamilton A; Guthkelch N; Lulu B; Obbens E; Rossman K; Shapiro W; Shetter A
Int J Radiat Oncol Biol Phys; 1992; 24(4):657-67. PubMed ID: 1429088
[TBL] [Abstract][Full Text] [Related]
14. Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma.
Chang EL; Loeffler JS; Riese NE; Wen PY; Alexander E; Black PM; Coleman CN
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):65-70. PubMed ID: 9422559
[TBL] [Abstract][Full Text] [Related]
15. [Value of radiosurgery in first-line therapy of glioblastoma multiforme. The Heidelberg experience and review of the literature].
van Kampen M; Engenhart-Cabillic R; Debus J; Fuss M; Rhein B; Wannenmacher M
Strahlenther Onkol; 1998 Apr; 174(4):187-92. PubMed ID: 9581178
[TBL] [Abstract][Full Text] [Related]
16. Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis.
Videtic GM; Gaspar LE; Zamorano L; Stitt LW; Fontanesi J; Levin KJ
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):963-8. PubMed ID: 11704318
[TBL] [Abstract][Full Text] [Related]
17. Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients.
Coughlin C; Scott C; Langer C; Coia L; Curran W; Rubin P
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1351-8. PubMed ID: 11121633
[TBL] [Abstract][Full Text] [Related]
18. CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.
Chatzikonstantinou G; Zamboglou N; Archavlis E; Strouthos I; Zoga E; Milickovic N; Hilaris B; Baltas D; Rödel C; Tselis N
Strahlenther Onkol; 2018 Dec; 194(12):1171-1179. PubMed ID: 30203110
[TBL] [Abstract][Full Text] [Related]
19. Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme.
Nwokedi EC; DiBiase SJ; Jabbour S; Herman J; Amin P; Chin LS
Neurosurgery; 2002 Jan; 50(1):41-6; discussion 46-7. PubMed ID: 11844233
[TBL] [Abstract][Full Text] [Related]
20. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
